The weekly litigation news digest is live. Subscribe now

IP Verse

A Process For Reduction And/Or Removal Of Fxi And Fxia From Solutions Containing Said Coagulation Factors - EP2640413

The patent EP2640413 was granted to Octapharma on Jun 12, 2019. The application was originally filed on Nov 16, 2011 under application number EP11784653A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP2640413

OCTAPHARMA
Application Number
EP11784653A
Filing Date
Nov 16, 2011
Status
Opposition Rejected
Apr 28, 2023
Publication Date
Jun 12, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

STRAWMANMar 12, 2020D YOUNGWITHDRAWN

Patent Citations (6) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP0131740
INTERNATIONAL-SEARCH-REPORTWO2006128497
INTERNATIONAL-SEARCH-REPORTWO2008081025
OPPOSITIONEP101913986
OPPOSITIONUS6069236
OPPOSITIONWO2012152953

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents